{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:25:22Z","timestamp":1782271522491,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alport syndrome (AS) is a kind of progressive hereditary nephritis induced by mutations of different genes that encode collagen IV. The affected individuals usually develop hematuria during childhood, accompanying with gradual deterioration of renal functions. In this study, the multi-pronged approach was employed to improve the diagnosis of AS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-two children were diagnosed and treated at the Department of Pediatric Nephrology of Jilin University First Hospital between January 2017 and January 2020 using the multi-pronged approach. The following information was collected from patients, including age of onset, age at diagnosis, clinical manifestations, family history, renal pathology and genotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All these 22 children were diagnosed with Alport syndrome according to the diagnostic criteria formulated by the Japanese Society of Nephrology (2015), among them, only 13 children met the diagnostic criteria released in 1988. All the 22 patients presented with hematuria, and proteinuria to varying degrees was observed in some patients. Three children suffered from hearing loss, but no child in the cohort had any visual problem or renal failure. Meanwhile, five patients were estimated to be at Stage 2, whereas the remaining 17 cases were at Stage 0. Renal biopsies were performed in 18 patients, including 14 showing glomerular basement membranes (GBM)-specific abnormalities. Moreover, 13 children were detected with mutations of genes encoding collagen IV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The multi-pronged approach helps to improve the diagnosis of AS. Most patients do not have renal failure during childhood, but close assessment and monitoring are necessary. Also, the advancements in treatment are reviewed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01962-y","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T08:03:26Z","timestamp":1595491406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China"],"prefix":"10.1186","volume":"21","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-2582","authenticated-orcid":false,"given":"Qing-shan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"25","key":"1962_CR1","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348(25):2543\u201356. https:\/\/doi.org\/10.1056\/NEJMra022296.","journal-title":"N Engl J Med"},{"key":"1962_CR2","doi-asserted-by":"publisher","first-page":"c9","DOI":"10.1159\/000320876","volume":"118","author":"CE Kashtan","year":"2011","unstructured":"Kashtan CE, Segal Y. Genetic disorders of glomerular basement membranes. Nephron Clin Pract. 2011;118:c9\u2013c18.","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/cge.12258","volume":"86","author":"C Fallerini","year":"2014","unstructured":"Fallerini C, Dosa L, Tita R, et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet. 2014;86(3):252\u20137. https:\/\/doi.org\/10.1111\/cge.12258.","journal-title":"Clin Genet"},{"issue":"12","key":"1962_CR4","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re V, Dahan K, Hilbert P, et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. 2014;25(12):2740\u201351. https:\/\/doi.org\/10.1681\/ASN.2013080912.","journal-title":"J Am Soc Nephrol"},{"key":"1962_CR5","doi-asserted-by":"publisher","unstructured":"Matthaiou A, Poulli T, Deltas C. Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review. Clin Kidney J. 2020:1\u201312. https:\/\/doi.org\/10.1093\/ckj\/sfz176.","DOI":"10.1093\/ckj\/sfz176"},{"issue":"3","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel J, Rubel D, Gross O. Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol. 2013;9(3):170\u20138. https:\/\/doi.org\/10.1038\/nrneph.2012.259.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1962_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00433075","volume":"364","author":"HJ Rumpelt","year":"1974","unstructured":"Rumpelt HJ, Langer KH, Sch\u00e4rer K, et al. Split and extremely thin glomerular basement membranes in hereditary nephropathy (Alport's syndrome). Virchows Archiv A. 1974;364(3):225.","journal-title":"Virchows Archiv A"},{"issue":"5","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2215\/CJN.07510712","volume":"8","author":"L Massella","year":"2013","unstructured":"Massella L, Gangemi C, Giannakakis K, et al. Prognostic Value of Glomerular Collagen IV Immunofluorescence Studies in Male Patients with X-Linked Alport Syndrome. Clin J Am Soc Nephrol Cjasn. 2013;8(5):749.","journal-title":"Clin J Am Soc Nephrol Cjasn"},{"issue":"1","key":"1962_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2215\/CJN.00200110","volume":"6","author":"H Hanson","year":"2011","unstructured":"Hanson H, Storey H, Pagan J, et al. The value of clinical criteria in identifying patients with X-linked Alport syndrome. Clin J Am Soc Nephrol. 2011;6(1):198\u2013203.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1962_CR10","first-page":"736","volume":"57","author":"K Nakanishi","year":"2015","unstructured":"Nakanishi K, Yoshikawa N. Alport syndrome. Nihon Jinzo Gakkai Shi. 2015;57(4):736\u201342.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"1962_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(88)90753-2","volume":"2","author":"FA Flinter","year":"1988","unstructured":"Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet. 1988;2:1005\u20137.","journal-title":"Lancet"},{"key":"1962_CR12","doi-asserted-by":"publisher","unstructured":"Kashtan CE, Ding J, Garosi G, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018;93(5):1045\u201351. https:\/\/doi.org\/10.1016\/j.kint.2017.12.018.","DOI":"10.1016\/j.kint.2017.12.018"},{"issue":"7","key":"1962_CR13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","volume":"17","author":"O Gross","year":"2002","unstructured":"Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002;17(7):1218\u201327. https:\/\/doi.org\/10.1093\/ndt\/17.7.1218.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1962_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.653","volume":"7","author":"X Zhao","year":"2019","unstructured":"Zhao X, Chen C, Wei Y, et al. Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport syndrome using next generation sequence technique. Mol Genet Genomic Med. 2019;7(6):e653. https:\/\/doi.org\/10.1002\/mgg3.653.","journal-title":"Mol Genet Genomic Med."},{"issue":"7","key":"1962_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.741","volume":"7","author":"S Shang","year":"2019","unstructured":"Shang S, Peng F, Wang T, et al. Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport syndrome. Mol Genet Genomic Med. 2019;7(7):e00741. https:\/\/doi.org\/10.1002\/mgg3.741.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"1962_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23(2):158\u201368. https:\/\/doi.org\/10.1007\/s10157-018-1629-4.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1962_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00467-006-0227-y","volume":"22","author":"M Charbit","year":"2007","unstructured":"Charbit M, Gubler MC, Dechaux M, et al. Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol. 2007;22(1):57\u201363.","journal-title":"Pediatr Nephrol"},{"key":"1962_CR18","doi-asserted-by":"publisher","unstructured":"Vischini G, Kapp ME, Wheeler FC, Hopp L, Fogo AB. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome. Hum Pathol. 2018;81:229\u201334. https:\/\/doi.org\/10.1016\/j.humpath.2018.02.024.","DOI":"10.1016\/j.humpath.2018.02.024"},{"issue":"12","key":"1962_CR19","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s11427-018-9545-3","volume":"62","author":"Z Li","year":"2019","unstructured":"Li Z, Zhu P, Huang H, et al. Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome. Sci China Life Sci. 2019;62(12):1572\u20139. https:\/\/doi.org\/10.1007\/s11427-018-9545-3.","journal-title":"Sci China Life Sci"},{"issue":"4","key":"1962_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","volume":"64","author":"J Savige","year":"2003","unstructured":"Savige J, Rana K, Tonna S, et al. Thin basement membrane nephropathy. Kidney Int. 2003;64(4):1169\u201378.","journal-title":"Kidney Int"},{"issue":"52","key":"1962_CR21","first-page":"2647","volume":"146","author":"E Endreffy","year":"2005","unstructured":"Endreffy E, Ondrik Z, Kem\u00e9ny E, et al. IV-es t\u00edpus\u00fa kollag\u00e9n nephropathi\u00e1k: a v\u00e9kony baz\u00e1lis membr\u00e1n nephropathi\u00e1t\u00f3l az Alport-szindr\u00f3m\u00e1ig [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome]. Orv Hetil. 2005;146(52):2647\u201353.","journal-title":"Orv Hetil"},{"key":"1962_CR22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oso\/9780192631466.003.0008","volume-title":"The Genetics of Renal Disease","author":"F Flinter","year":"2004","unstructured":"Flinter F. Alport Syndrome. In: The Genetics of Renal Disease. Oxford: Oxford University Press; 2004. p. 183\u201395."},{"issue":"1","key":"1962_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ekir.2016.09.056","volume":"2","author":"SM Said","year":"2016","unstructured":"Said SM, Fidler ME, Valeri AM, et al. Negative Staining for COL4A5 correlates with worse prognosis and more severe ultrastructural alterations in males with Alport Syndrome. Kidney Int Rep. 2016;2(1):44\u201352. Published 2016 Sep 29. https:\/\/doi.org\/10.1016\/j.ekir.2016.09.056.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"1962_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura Y, Nozu K, Kaito H, et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV \u03b15 chain. Kidney Int. 2014;85(5):1208\u201313. https:\/\/doi.org\/10.1038\/ki.2013.479.","journal-title":"Kidney Int"},{"issue":"10","key":"1962_CR25","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.asn.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \"European Community Alport Syndrome Concerted Action\" study. J Am Soc Nephrol. 2003;14(10):2603\u201310. https:\/\/doi.org\/10.1097\/01.asn.0000090034.71205.74.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1962_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/humu.20091","volume":"24","author":"AV Persikov","year":"2004","unstructured":"Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B. Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat. 2004;24(4):330\u20137. https:\/\/doi.org\/10.1002\/humu.20091.","journal-title":"Hum Mutat"},{"issue":"7","key":"1962_CR27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","volume":"34","author":"J Savige","year":"2019","unstructured":"Savige J, Ariani F, Mari F, et al. Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatr Nephrol. 2019;34(7):1175\u201389. https:\/\/doi.org\/10.1007\/s00467-018-3985-4.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1962_CR28","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1681\/ASN.2007040444","volume":"18","author":"K Voskarides","year":"2007","unstructured":"Voskarides K, Damianou L, Neocleous V, et al. COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007;18(11):3004\u201316. https:\/\/doi.org\/10.1681\/ASN.2007040444.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1962_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, et al. Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015;52(3):163\u201374. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102822.","journal-title":"J Med Genet"},{"issue":"1","key":"1962_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cge.12919","volume":"92","author":"C Fallerini","year":"2017","unstructured":"Fallerini C, Baldassarri M, Trevisson E, et al. Alport syndrome: impact of digenic inheritance in patients management. Clin Genet. 2017;92(1):34\u201344. https:\/\/doi.org\/10.1111\/cge.12919.","journal-title":"Clin Genet"},{"issue":"1","key":"1962_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-015-3184-5","volume":"31","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang F, Ding J, et al. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Pediatr Nephrol. 2016;31(1):67\u201372. https:\/\/doi.org\/10.1007\/s00467-015-3184-5.","journal-title":"Pediatr Nephrol"},{"key":"1962_CR32","doi-asserted-by":"publisher","first-page":"436046","DOI":"10.5402\/2012\/436046","volume":"2012","author":"O Gross","year":"2012","unstructured":"Gross O, Friede T, Hilgers R, et al. Safety and efficacy of the ACE-inhibitor Ramipril in Alport syndrome: the double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport Trial in pediatric patients. ISRN Pediatr. 2012;2012:436046. https:\/\/doi.org\/10.5402\/2012\/436046.","journal-title":"ISRN Pediatr"},{"issue":"Suppl 4","key":"1962_CR33","doi-asserted-by":"publisher","first-page":"iv124","DOI":"10.1093\/ndt\/gfu028","volume":"29","author":"O Gross","year":"2014","unstructured":"Gross O, Perin L, Deltas C. Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies. Nephrol Dial Transplant. 2014;29(Suppl 4):iv124\u201330. https:\/\/doi.org\/10.1093\/ndt\/gfu028.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1962_CR34","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfz131","volume":"34","author":"R Torra","year":"2019","unstructured":"Torra R, Furlano M. New therapeutic options for Alport syndrome. Nephrol Dial Transplant. 2019;34(8):1272\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfz131.","journal-title":"Nephrol Dial Transplant"},{"key":"1962_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/IJNRD.S150539","volume":"11","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE. Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation. Int J Nephrol Renovasc Dis. 2018;11:267\u201370. Published 2018 Oct 16. https:\/\/doi.org\/10.2147\/IJNRD.S150539.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"3","key":"1962_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ekir.2018.01.008","volume":"3","author":"V Gillion","year":"2018","unstructured":"Gillion V, Dahan K, Cosyns JP, et al. Genotype and Outcome After Kidney Transplantation in Alport Syndrome. Kidney Int Rep. 2018;3(3):652\u201360. Published 2018 Feb 2. https:\/\/doi.org\/10.1016\/j.ekir.2018.01.008.","journal-title":"Kidney Int Rep"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01962-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T13:20:23Z","timestamp":1723296023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01962-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01962-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-15777\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-15777\/v2","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Jilin University First Hospital. All mentioned data were accessed with the approval of the hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were provided by the parents of patients for the publication of case history and clinical results. A copy of the written consent was available for the review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}